Novocol Pharmaceutical of Canada, Inc.
FDA inspection history in Cambridge, Canada, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Cambridge, Canada.
Cited most
Across all Novocol Pharmaceutical of Canada observations on file
- 21 CFR 211.113(b)Control of microbiological contamination1
The complete Novocol Pharmaceutical of Canada file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Cambridge, Canada
One Form 483 · 2019 · 1 observation
Latest: Form 483, Jun 18, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-06-18 | 483 Form 483 | Cambridge, Canada | 1 | $99 |
Investigators on these documents
FEI number 3002807757 · most recent document Jun 18, 2019
About Novocol Pharmaceutical of Canada, Inc.
How many FDA Form 483s has Novocol Pharmaceutical of Canada, Inc. received?
FDA Intel has 1 Form 483 on file for Novocol Pharmaceutical of Canada, Inc.; the most recent is dated Jun 18, 2019.
When was Novocol Pharmaceutical of Canada, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Novocol Pharmaceutical of Canada, Inc. is a Form 483 dated Jun 18, 2019, for the site in Cambridge, Canada.
What did FDA cite at Novocol Pharmaceutical of Canada, Inc.?
The regulations cited most in the observations on file for Novocol Pharmaceutical of Canada, Inc. are 21 CFR 211.113(b) (Control of microbiological contamination), 1 time.